These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22993739)

  • 21. [Hypertension and medication compliance: a challenge every day].
    Vuignier Y; Burnier M; Waeber B; Wuerzner G
    Praxis (Bern 1994); 2014 Dec; 103(25):1515-9. PubMed ID: 25491054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valsartan-amlodipine-hydrochlorothiazide: the definitive fixed combination?
    Barrios V; Escobar C
    Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1609-18. PubMed ID: 21090936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Home blood pressure monitoring as good as office monitoring].
    Wallin J; Drevenhorn E; Nyström F
    Lakartidningen; 2011 Mar 2-8; 108(9):469-70. PubMed ID: 21744612
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination agents as a means of improving adherence and other aspects of the sixth Joint National Committee Report.
    Basile JN
    South Med J; 2000 May; 93(5):534-6. PubMed ID: 10832960
    [No Abstract]   [Full Text] [Related]  

  • 25. [Medication adherence and monitoring of antihypertensive treatment].
    Eskås PA; Heimark S; Mariampillai JE; Larstorp AC; Fadl Elmula FE; Høieggen A
    Tidsskr Nor Laegeforen; 2016 Jun; 136(10):920-3. PubMed ID: 27272370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [How to assess and to improve adherence in clinical practice?].
    Márquez Contreras E; Márquez Rivero S; Rodríguez García E; Baldonedo Suárez A
    Hipertens Riesgo Vasc; 2017 Jan; 34 Suppl 1():29-35. PubMed ID: 29703400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significance of ambulatory pressure monitoring in the assessment of antihypertensive agents].
    Mancia G; Bertinieri G; Stella ML; Grassi G
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):335-8. PubMed ID: 12497930
    [No Abstract]   [Full Text] [Related]  

  • 28. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
    Mallion JM; Genès N; Vaur L; Clerson P; Vaïsse B; Bobrie G; Chatellier G
    J Hum Hypertens; 2001 Dec; 15(12):841-8. PubMed ID: 11773986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood pressure-lowering effect and duration of action of bedtime administration of doxazosin determined by home blood pressure measurement.
    Gonokami K; Obara T; Kobayashi M; Katada S; Hara A; Metoki H; Asayama K; Kikuya M; Ohkubo T; Imai Y
    Clin Exp Hypertens; 2010; 32(5):311-7. PubMed ID: 20662733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
    Tocci G; Palano F; Pagannone E; Chin D; Ferrucci A; Volpe M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
    Abe M; Okada K; Matsumoto K
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Home blood pressure for the management of hypertension: will it become the new standard of practice?
    Krakoff LR
    Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):745-51. PubMed ID: 21714605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MY APPROACH to the patient with hard-to-control hypertension.
    Weber MA
    Trends Cardiovasc Med; 2015 Nov; 25(8):755-6. PubMed ID: 26410542
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Timing of antihypertensive therapy and circadian blood pressure pattern.
    Almirall J; Martínez-Ocaña JC; Comas L
    Hypertension; 2009 Jun; 53(6):e41; author reply e42. PubMed ID: 19414642
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapeutic compliance and follow-up of hypertensive patients in primary care].
    Sanchis Doménech C; Vara González LA
    Med Clin (Barc); 2012 Jun; 139(3):126-30. PubMed ID: 22281095
    [No Abstract]   [Full Text] [Related]  

  • 37. [Ambulatory blood pressure monitoring in the therapeutic assessment of arterial hypertension].
    Amodeo C
    Arq Bras Cardiol; 1996 Aug; 67(2):143-4. PubMed ID: 9110448
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of electronic monitoring of drug adherence on blood pressure control in primary care: a cluster 12-month randomised controlled study.
    Santschi V; Rodondi N; Bugnon O; Burnier M
    Eur J Intern Med; 2008 Oct; 19(6):427-34. PubMed ID: 18848176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Compliance promoting hypertension therapy. With early fixed combination more rapid target reading].
    Einecke D
    MMW Fortschr Med; 2012 Apr; 154(7):29. PubMed ID: 22558867
    [No Abstract]   [Full Text] [Related]  

  • 40. A role for single-pill triple therapy in hypertension.
    Elijovich F; Laffer C
    Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):231-40. PubMed ID: 19443512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.